Publications by authors named "Max Pan"

Claim this Profile
S
SARS-CoV-2 Evolution in Humans Enables Its Transmission to Nonhuman Primates.
Yu-Ting Chiu, Yu-Sung Huang, Max Yu-Chen Pan, Chih-Yao Chang, Chih-Chien Chiu

Mol Biol Evol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Therapeutic Impact of AXL Inhibitor AB-329: Chemotherapy Sensitization and Immune Microenvironment Reprogramming in TNBC.
Dileep Reddy Rampa, Jon A Fuson, Huey Liu, Max Pan, Yujia Qin

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules.
Yuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, Ming-Hong Chao, Mu-Chun Li, Max Yu-Chen Pan, Hsing-Pang Hsieh

Dev Cell· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products.
Chen-Wei Li, Tai-Ling Chao, Chin-Lan Lai, Cheng-Chin Lin, Max Yu-Chen Pan

ACS Omega· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors.
Srinivasa Rao Palla, Chen-Wei Li, Tai-Ling Chao, Hoi-Ling Vienn Lo, Jia-Jin Liu, Max Yu-Chen Pan

Antiviral Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRUST-II: a global phase II study of taletrectinib in -positive non-small-cell lung cancer and other solid tumors.
Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang-Min Choi, Nong Yang, Max Pan

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette package labels to promote lung cancer screening.
Simar S Bajaj, Max Pan, Alexandra L Potter, Chi-Fu Jeffrey Yang

Nat Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical-induced degradation of PreS2 mutant surface antigen via the induction of microautophagy.
Joey Yi Yang, Yi-Hsuan Wu, Max Yu-Chen Pan, Yu-Ting Chiou, Richard Kuan-Lin Lee

Antiviral Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor BAP1 nuclear import is governed by transportin-1.
Tzu-Jing Yang, Tian-Neng Li, Rih-Sheng Huang, Max Yu-Chen Pan, Shu-Yu Lin

J Cell Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2.
Richard Kuan-Lin Lee, Tian-Neng Li, Sui-Yuan Chang, Tai-Ling Chao, Chun-Hsien Kuo, Max Yu-Chen Pan, Hsing-Pang Hsieh

Int J Mol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets.
Pei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan

Pharmaceutics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclinic 122-Type BaIr₂Ge₂ with a Channel Framework: A Structural Connection between Clathrate and Layered Compounds.
Xin Gui, Tay-Rong Chang, Tai Kong, Max T Pan, Robert J Cava

Materials (Basel)· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.
Wenqing Yao, Jincong Zhuo, David M Burns, Yun-Long Li, Ding-Quan Qian, Max Pan

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.
David M Burns, Chunhong He, Yanlong Li, Peggy Scherle, Xiangdong Liu, Max Pan

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.
Wenqing Yao, Jincong Zhuo, David M Burns, Meizhong Xu, Colin Zhang, Max Pan

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis